2026-06-16 23:30:14
Latest Post
Tembo Global Industries Approves 1:10 Stock Split; Converts 4.05 Lakh Warrants into Equity Shares
Aurionpro partners with Ajman Bank to advance Islamic Treasury Systems validation
Federal Bank introduces special FCNR deposits offering interest rates of 6.25% per annum
NIIT Learning Systems Ltd named Global Authorized Training Partner of the Year by Databricks, 2026
Nibe Ltd refutes misleading allegations regarding Army Purchase Order for supply of Suryastra Rocket Launcher Systems
Stock Report
Zydus announces the successful completion of acquisition of Assertio Holdings
Posted On : 2026-06-16 19:36:29( TIMEZONE : IST )
Zydus Lifesciences Ltd. (the "Company") today announced the successful completion of the cash tender offer, through its wholly-owned subsidiary, Zara Merger Sub Inc. (the "Purchaser") for all the outstanding shares of common stock of Assertio Holdings, Inc. (Nasdaq: ASRT) ("Assertio").
The Company and Purchaser completed the cash offer at a purchase price of $23.50 per share of common stock of Assertio, without interest, less deduction for any required withholding taxes. As of the tender offer expiration at one minute after 11:59 p.m., Eastern Time, on June 15, 2026, 4,286,488 shares of common stock were validly tendered and not withdrawn, representing approximately 66.32% of the total number of Assertio's issued and outstanding shares of common stock. All such shares have been accepted for payment in accordance with the terms of the tender offer, and the Company expects to promptly pay for such shares.
The Company intends to complete the acquisition on June 16, 2026 through a merger of Purchaser with and into Assertio, with Assertio continuing as the surviving corporation, in which all shares of common stock not tendered into the offer will be cancelled and converted into the right to receive cash equal to the $23.50 offer price per common share, without interest, less deduction for any required withholding taxes. After the completion of the merger, Assertio will become a wholly owned subsidiary of the Company, and the common stock of Assertio will no longer be listed or traded on the Nasdaq Global Market.
Shares of Zydus Lifesciences Limited was last trading in BSE at Rs. 1078.40 as compared to the previous close of Rs. 1087.75. The total number of shares traded during the day was 39392 in over 1781 trades.
The stock hit an intraday high of Rs. 1090.45 and intraday low of 1073.00. The net turnover during the day was Rs. 42508753.00.
